P. Goldfarb

A safety and efficacy study of bleomycin sulfate and electroporation in patients with metastatic or locally recurrent breast cancer

V Paramanov, O Tyurin, Sergey Polenkov, P. Goldfarb

The study evaluated bleomycin sulfate (BS) followed by electroporation (EP) treatment in patients with recurrent in-breast or chest-wall tumors. EP treatment following intralesional injection of BS has been studied in various cancers, and significantly increased destruction of cancer cells within the treatment …

ua, us (code pays fourni par la source)

526 WOUND HEALING FOLLOWING ELECTROPORATION THERAPY IN A PORCINE MODEL.

Z. A. Filip, Donald P. Speer, Michael J. Demeure, Amanda Valles et autres

Currently one of the greatest obstacles facing effective anticancer molecular therapies is efficient drug delivery. Advanced methods such as carriers, liposomes, ultrasound, and viruses have generated modest results with unresolved technical, economical, and regulatory problems. Conventional therapies such as radiation and chemotherapy …

us (code pays fourni par la source)

The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck

David C. Bloom, P. Goldfarb

us (code pays fourni par la source)

975 A phase I/II single arm trial to determine the safety, tolerability, and biological activity of intrahepatic delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers (MTC-DOX) in patients with metastatic tumors in the liver

Richard G. Just, Carl K. Hoh, Thomas Joseph Vogl, Patrice Y. Neese et autres

Phase II studies using electroporation therapy in patients with recurrent head and neck cancer: a safe and active treatment approach

P. Goldfarb, Fiona H. Hill

Re: Treatment Available to Regenerate Bone

P. Goldfarb, Delbert L. Booher